Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

32.96
-0.3796-1.14%
Post-market: 33.050.0854+0.26%16:10 EDT
Volume:1K
Turnover:46.07K
Market Cap:42.03M
PE:- -
High:33.17
Open:33.17
Low:32.95
Close:33.34
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.18
T/O Rate:0.11%
Dividend:0.08
Dividend Rate:0.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Sep 17

GenScript Biotech Hits Near 5-Year High on Eli Lilly Collaboration

Reuters
·
Sep 17

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Reuters
·
Sep 17

Legend Biotech CEO Ingrid Zhang Files Initial Beneficial Ownership Statement

Reuters
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Sector Update: Healthcare

MT Newswires Live
·
Sep 16

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS
·
Sep 16

Circle Pharma Raises $92.5 Million in Series E Funding Led by Column Group

Reuters
·
Sep 16

Twist Bioscience Corporation - to Provide Antibody Characterization Data Services for Lilly Tunelab

THOMSON REUTERS
·
Sep 16

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
Sep 16

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
Sep 16

Circle Pharma: Financing Led by Column Group, Participation from Nextech Invest, Ra Capital Management, Strategic Investment from Eli Lilly and Co

THOMSON REUTERS
·
Sep 16

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Reuters
·
Sep 16

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Sep 16

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Sep 16

Ascendis Pharma A/S Stock (ASND) Moved Down by 12.08% on Sep 15: What Signal Does It Send?

TradingKey
·
Sep 16

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU
·
Sep 16

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Sep 15

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Sep 15